Numerical selection of optimal tumor imaging agents with application to engineered antibodies

Cancer Biotherapy and Radiopharmaceuticals

Volumn 16, Issue 1, 2001, Pages 25-35

  Williams, L E ^a   Wu, A M ^a   Yazaki, P J ^a   Liu, A ^a   Raubitschek, A A ^a   Shively, J E ^a   Wong, J Y C ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Deconvolution; IFOM; Monoclonal antibody; Protein engineering

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHIMERIC ANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G1; IODINE 123; IODINE 125; IODINE 131; MONOCLONAL ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORECTAL TUMOR; DRUG DISTRIBUTION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 0035086518     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497801750095989     Document Type: Article

References (26)

1. Monoclonal antibodies in diagnosis and therapy
2. Use of radiolabeled antibodies to CEA for the detection and localization of diverse cancers by external photoscanning
3. Figures of merit (FOMs) for imaging and therapy using monoclonal antibodies
4. 2 and Fab fragments and recombinant single chain Fv in a human tumor xenograft model
5. Biodistribution of an indium-111- or yttrium-90-labelled chimeric anti-carcinoembryonic antigen monoclonal antibody (cT84.66) following its large scale production in a bioreactor
6. H3) which exhibits rapid, high-level targeting of xenografts
7. Tumor localization of anti-CEA single-chain Fvs: Improved targeting by non-covalent dimers
8. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv
9. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse genes in myeloma and Chinese hamster ovary cells
10. Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis
11. Binding parameters of antibodies - A reappraisal
12. Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs
13. Iodination of proteins, glycoproteins and peptides using a solid-phase oxidizing agent
14. A program package for simulation and parameter estimation in pharmacokinetic systems
15. Determination of regional cerebral blood flow by inhalation of 133-Xenon
16. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies
17. Anti-carcinoembryonic antigen (CEA) diabody for rapid tumor targeting and imaging
18. Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu
19. L-lysine effectively blocks renal uptake of I-125 and Tc-99m labeled anti-Tac disulfide B stabilized Fv fragment
20. Construction, binding properties, metabolism and targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49
21. Clinical evaluation of an 111In labeled anti-CEA chimeric monoclonal antibody (cT84.66)
22. Pre-targeted imunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens
23. Bifunctional antibody: A binary radiopharmaceutical delivery system for imaging colorectal carcinoma
24. Truncation of blood curves to enhance imaging and therapy with monoclonal antibodies